Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Viruses causing upper respiratory infections" refers to a large and diverse group of viruses (not a single molecule or receptor) that infect the mucosa of the upper respiratory tract, causing acute illnesses such as the common cold, pharyngitis, sinusitis, and laryngitis. The most prevalent agents include rhinoviruses (responsible for up to 80% of common colds), human coronaviruses (excluding SARS/MERS), influenza viruses (possible upper/lower involvement), parainfluenza viruses, adenoviruses, respiratory syncytial virus (RSV), enteroviruses, human metapneumovirus, and bocavirus[1][4][5][6][7]. There is no unifying receptor or molecular target for this group; each virus has distinct entry mechanisms, replication cycles, and epidemiological behaviors. Most infections are self-limiting, but complications and more severe illnesses are common in specific populations. Pharmacological interventions are limited to specific subtypes (e.g., influenza antivirals, RSV monoclonal antibodies), and the inappropriate use of antibiotics remains a significant public health concern[2][7].
Neuraminidase inhibition (influenza); RNA polymerase inhibition (selected viral polymerases); Monoclonal antibody neutralization (RSV); General symptom relief (supportive, not viral-targeted)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viruses causing upper respiratory infections.